News

Is V a good stock to buy? We came across a bullish thesis on Visa Inc. on Evangelos Pardalis – Public Portfolio’s Substack by Evangelos Pardalis. In this article, we will summarize the bulls’ thesis on V. Visa Inc.’s share was trading at $313.94 as of April 20th. V’s trailing and forward P/E were 29.48 and 24.39 respectively according to Yahoo […]

Is WM a good stock to buy? We came across a bullish thesis on Waste Management, Inc. on Roche Capital’s Substack by Pedro Ortiz. In this article, we will summarize the bulls’ thesis on WM. Waste Management, Inc.’s share was trading at $224.18 as of April 20th. WM’s trailing and forward P/E were 33.46 and 27.17 respectively according to Yahoo Finance. […]

Is AXTI a good stock to buy? We came across a bullish thesis on AXT, Inc. on PhotonCap’s Substack. In this article, we will summarize the bulls’ thesis on AXTI. AXT, Inc.’s share was trading at $78.76 as of April 20th. AXTI’s forward P/E was 24.21 according to Yahoo Finance. AXT, Inc. designs, develops, manufactures, and distributes compound and single-element semiconductor […]

Halozyme Therapeutics, Inc. (NASDAQ:HALO) ranks among the most profitable biotech stocks to buy now. On April 13, TD Cowen reaffirmed its Buy rating and $96 price target for Halozyme Therapeutics, Inc. (NASDAQ:HALO). The firm forecasts Halozyme to continue to outperform expectations and enhance guidance due to strong growth catalysts such as Vyvgart Hytrulo, Darzalex Faspro, […]

Most investors see a stock drop 13% after a bad earnings report and walk away. One of the most closely watched portfolio managers in the market saw the same setup and moved in the opposite direction. What Cathie Wood's ARK Invest did the very next morning is the kind of move that forces the market ...

Chevron faced some war-driven headwinds in the first quarter.

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the ones that make you life-changing money.

Shareholders of ZIM Integrated Shipping Services approved the merger with Hapag Lloyd in a recent vote. The proposed compensation policy for executives was rejected in the same meeting, raising governance concerns. The merger decision and compensation vote arrive as ZIM trades at $26.28 under ticker NYSE:ZIM. For investors watching NYSE:ZIM, the merger approval with Hapag Lloyd comes after a period of strong share price performance, with the stock up 19.9% year to date and 87.8% over the...

Uber Technologies (UBER) just rolled out in app hotel bookings with Expedia and deepened its autonomous fleet work through a new Hertz Oro Mobility partnership, moves that reinforce its push toward an integrated travel and rides platform. See our latest analysis for Uber Technologies. Despite the steady stream of product launches, partnerships and legal headlines in recent weeks, Uber’s share price return has been mixed, with a 4.76% one-month gain but a 9.34% year-to-date decline. The...

TSMC (NYSE:TSM) has decided to delay deployment of ASML’s high numerical aperture EUV lithography machines for several years. The company plans to keep pushing its current EUV and DUV tools for upcoming chip generations instead of moving quickly to the newest gear. At the same time, TSMC is expanding partnerships around next generation AI silicon design with key industry customers and ecosystem players. This shift affects how quickly leading edge manufacturing and AI focused chips may roll...

Mark Cuban isn't grading for style points—he's grading for impact. The billionaire co-founder of Cost Plus Drugs revisited TrumpRx and made clear what matters most: if it pressures the right players, it's working. From "B" To ‘A-' — Why The...

HVAC company Trane (NYSE:TT) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 6% year on year to $4.97 billion. Its non-GAAP profit of $2.63 per share was 3.9% above analysts’ consensus estimates.

These AI winners surged in April, but upcoming earnings will decide if their rally has more room to run.

Some investors may be wondering whether Alphabet is starting to look expensive or still offers value, even after a strong run in its share price. The stock last closed at US$385.69, with returns of 12.0% over 7 days, 29.7% over 30 days, 22.4% year to date and 135.9% over the past year, which naturally raises questions about growth expectations and risk. Recent headlines have focused on Alphabet's ongoing investments in artificial intelligence and cloud services, as well as regulatory...

Consumer discretionary names live or die on whether households feel comfortable opening their wallets, and right now those signals are flashing in opposite directions. Right now those signals are crossing in unusual directions: the University of Michigan Consumer Sentiment Index sits at 53.3 in March 2026, deep in what economists treat as recessionary territory, yet ... Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and Microsoft Corporation (NASDAQ:MSFT) ranks 10th on this list. Microsoft Corporation (NASDAQ:MSFT) is a long-term stock pick of Tom Steyer. His fund first disclosed a stake in the company back in the fourth quarter of 2010. Back then, this position comprised just under […]

It's been a good week for The Coca-Cola Company ( NYSE:KO ) shareholders, because the company has just released its...

(Bloomberg) -- Berkshire Hathaway Inc.’s cash pile soared to its highest level ever and operating earnings jumped in Greg Abel’s first quarter as chief executive officer.Most Read from BloombergSupertanker Appears to Have Crossed the Strait of HormuzBeijing Tells China Firms to Ignore US Sanctions on RefinersWorld’s Largest Container Carrier Plans Route Avoiding HormuzPhilippines Says Thousands Evacuated as Mayon Volcano EruptsTrump Casts Doubts on Iran Peace Proposal as Details EmergeAfter a sl

If you are wondering whether Applied Optoelectronics at US$183.51 is still offering value after a huge run, this article walks through the key numbers that matter for you. The stock has seen sharp moves recently, with returns of 13.2% over 7 days, 76.6% over 30 days and 363.4% year to date, while the 1 year and 3 year returns are very large multiples of the starting price. Recent coverage has focused on Applied Optoelectronics as a high momentum name in the communications and optical...

(Bloomberg) -- First-quarter earnings season is delivering Wall Street better-than-expected results, propelling US equities’ run from one record to the next.Most Read from BloombergSupertanker Appears to Have Crossed the Strait of HormuzWorld’s Largest Container Carrier Plans Route Avoiding HormuzBeijing Tells China Firms to Ignore US Sanctions on RefinersPhilippines Says Thousands Evacuated as Mayon Volcano EruptsIran Juggles Oil Cuts and Storage Strain to Resist US BlockadeAs earnings wind dow

Powell's tenure at the Fed began with a volatility shock. It's ending with a monster cross-asset rally.

A surge in AI-driven technology stocks reshaped global billionaire rankings in April, pushing Google co-founder Larry Page into the $300 billion club while keeping Elon Musk at the top of the world's richest list, according to Forbes’ compilation as of 12 a.m. EST on Friday. April was a strong month for markets. The S&P 500 rose 10.4%, its best monthly performance since November 2020, while the Nasdaq climbed 15.3%, marking its strongest gain since April 2020. The rally lifted the combined net w

Halozyme Therapeutics has seen its modelled Fair Value price target updated to $85.78 from $84.89, reflecting a modest recalibration in the latest assumptions. Analysts linking this change to current research point to royalty streams, ENHANZE collaborations, and acquired subcutaneous platforms as key factors shaping views on valuation and execution risk. As you read on, you will see how these moving pieces feed into the evolving narrative around Halozyme and what to watch next in the...

Lemonade's in-force premium growth just accelerated for the 10th consecutive quarter.

Broadcom leads a group of five stocks showing buy signs. Others include industrial companies, a mining outfit, and a promising data center stock.

Novo Nordisk (CPSE:NOVO B) is rolling out its oral Ozempic (semaglutide) tablet across the US as the only FDA approved oral GLP-1 for adults with type 2 diabetes. The company plans broad distribution through more than 70,000 US pharmacies. New access partnerships with WW International and GoodRx aim to support patients through digital health tools, discounts and self pay options. The launch includes a mix of insurance coverage pathways and cash pay programs targeting both insured and self...

Nebius Group (NasdaqGS:NBIS) agreed to acquire Eigen AI for approximately US$643 million in cash and stock. The deal brings Eigen AI’s model optimization and inference technology into Nebius’s Token Factory managed inference platform. Eigen AI’s team will form Nebius’s first engineering and research hub in the San Francisco Bay Area. Nebius Group focuses on AI infrastructure, and this acquisition plugs directly into that core line of business by targeting model optimization and inference...